McClellan joins J&J's board

Johnson & Johnson (NYSE:JNJ) appointed former FDA Commissioner Mark McClellan to its board. McClellan was FDA commissioner from 2002-04 and was CMS administrator from 2004-06. He is a senior fellow an...